Fort Sheridan Advisors »

Intellia Therapeutics shares owned by Fort Sheridan Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Fort Sheridan Advisors from 13F filings

Historical chart of Fort Sheridan Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Fort Sheridan Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Fort Sheridan Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $232k 7.3k 31.62
2023-06-30 $299k 7.3k 40.78
2023-03-31 $273k 7.3k 37.27
2022-12-31 $241k 6.9k 34.89
2022-09-30 $387k 6.9k 55.92
2022-06-30 $358k 6.9k 51.73
2022-03-31 $411k 5.7k 72.61
2021-12-31 $669k 5.7k 118.20
2021-09-30 $759k 5.7k 134.10
2021-06-30 $916k 5.7k 161.84
2021-03-31 $454k 5.7k 80.21
2020-12-31 $305k 5.6k 54.45